Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HW091077 Phase II study in refractory/unexplained chronic cough
ChiCTR2600125817Phase 2Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of HW091077 in refractory chronic cough (RCC) and chronic idiopathic cough (CIC) (3 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: Change in 24-hour cough frequency from baseline at Day 28. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
HW091077
03
Conditions
refractory chronic cough (RCC)chronic idiopathic cough (CIC)
Beyond the preview
Go deeper on ChiCTR2600125817.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600125817.